U.S. Department of Health & Human Services
National Institutes of Health
NCATS
This repository is under review for potential modification in compliance with Administration directives.
Dismiss
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Show Filters
Hide Filters
Development Status
US Approved Rx
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Approval Year
2014
1
2022
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Class
Protein
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Code System
CAS
2
DAILYMED
2
DRUG BANK
2
FDA ORPHAN DRUG
2
FDA UNII
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Protein Type
MONOCLONAL ANTIBODY
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 1
ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 2
ANTINEOPLASTIC AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 3
OTHER ANTINEOPLASTIC AGENTS
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
ATC Level 4
Monoclonal antibodies
1
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Substance Form
Principal Form
2
SHOW MORE...
SHOW LESS
All Match
Any Match
Exclude Selected
Exclude Selected
Clear
Apply
Search results for
"ORPHAN DRUG|Designated/Approved|Treatment of stage IIb to IV melanoma"
in
comments
(approximate match)
Showing
1 - 2
of
2
results
Search within data set
First page disabled
Previous page disabled
1
Next page disabled
Next page disabled
Sort By
Approval Year, Recent
Approval Year, Oldest
Relevance
Display Name, A-Z
Display Name, Z-A
Least References
Most References
Oldest Change
Newest Change
RELATLIMAB
MORE DETAILS
AF75XOF6W3
Subunit
1
(446) Similarity Search
Subunit
2
(446) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(446) Similarity Search
Subunit
2
(446) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2022)
First approved in 2022
Class:
PROTEIN
NIVOLUMAB
MORE DETAILS
31YO63LBSN
Subunit
1
(440) Similarity Search
Subunit
2
(440) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Export Data
Sequence Search
Subunit
1
(440) Similarity Search
Subunit
2
(440) Similarity Search
Subunit
3
(214) Similarity Search
Subunit
4
(214) Similarity Search
Status:
US Approved Rx (2014)
First approved in 2014
Class:
PROTEIN
